Delfina Care Inc. (Delfina), a healthcare technology company solving the maternal health crisis with an AI-powered care system, announced the successful close of its $17 million Series A funding round led by U.S. Venture Partners (USVP). The investment underscores Delfina's rapid progress in its mission to transform pregnancy care by delivering equitable access to individualized insights and integrated systems that improve health outcomes..

Delfina Care Inc.（Delfina）是一家利用人工智能医疗系统解决孕产妇健康危机的医疗技术公司，该公司宣布成功结束由美国风险投资伙伴（USVP）牵头的1700万美元a轮融资。这项投资突显了德尔菲纳在转变妊娠护理方面取得的快速进展，该公司通过提供公平的个性化见解和综合系统来改善健康状况。。

The Series A round was led by U.S. Venture Partners (USVP) and included participation from new investors ARTIS Ventures, Mayo Clinic, and Tokio Marine Future Fund. Delfina's existing investors also participated in the round, including Story Ventures, SemperVirens, Bread and Butter Ventures, Boutique Ventures, and Chelsea Clinton's Metrodora Ventures..

。德尔菲纳的现有投资者也参与了这轮投资，包括Story Ventures、SemperVirens、面包和黄油风险投资、精品风险投资和切尔西·克林顿的Metrodora风险投资。。